Skip to content
WeighLab
Menu
Ranked #480 · Grade C

Meto review

Meto is a bloodwork-driven peptide membership platform ($29/mo base + $149 labs) whose GLP-1 offering is a single bundled 'GLP-1 Family' line at $199/mo covering both semaglutide and tirzepatide without separating the two.

Visit Meto Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$199/mo (starting dose, plus a separate fee, compounded)
Tirzepatide
$199/mo (starting dose, plus a separate fee, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Semaglutide · modeled / year

$2,388

Tirzepatide · modeled / year

$2,388

Pricing verified August 2026

The Index scorecard

Meto scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month41/100
Price Transparency20/100
Nationwide Access24/100
Formulation Options66/100
Clinical Oversight80/100
Contract Flexibility55/100

Where the value is

  • Requires actual bloodwork/metabolic panel before prescribing, a stronger clinical gate than many peers
  • Transparent line-item pricing across a wide menu of protocols
  • Combined GLP-1 pricing is comparatively affordable relative to single-drug peers
  • No prepay or promo-trap language detected in published pricing

The tradeoffs

  • GLP-1 is a minor line item on a broader peptide platform, not the core focus
  • Semaglutide and tirzepatide are not priced or dosed separately -- shoppers can't compare against single-drug competitors cleanly
  • Mandatory $149 lab panel and $29/mo membership are additive costs easy to miss when comparing headline price
  • No medical director, named pharmacy, states-served list, or LegitScript certification disclosed

The bottom line

Best for: Cost-first shoppers who want peptide/longevity enthusiasts who want lab-verified dosing across multiple protocols, not GLP-1-first shoppers. Meto is a bloodwork-driven peptide membership platform ($29/mo base + $149 labs) whose GLP-1 offering is a single bundled 'GLP-1 Family' line at $199/mo covering both semaglutide and tirzepatide without separating the two.

Ranked #480 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Meto.

The 24 programs nearest this one

Pricing, states and verification reflect Meto's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Meto's site. Not medical advice; see our disclosure.

← Back to the value leaderboard